June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Comparative expression analysisin plasma ofcirculating microRNAs identified in ocular fluids as putative biomarkers for diabetic retinopathy
Author Affiliations & Notes
  • Zeljka Smit-McBride
    Vitreo-Retinal Research Lab, Univ of California, Davis Sch of Med, Davis, CA
  • Kingsley Okafor
    Vitreo-Retinal Research Lab, Univ of California, Davis Sch of Med, Davis, CA
  • Anthony T Nguyen
    Vitreo-Retinal Research Lab, Univ of California, Davis Sch of Med, Davis, CA
  • Matthew Bordbari
    Vitreo-Retinal Research Lab, Univ of California, Davis Sch of Med, Davis, CA
  • Amar P Patel
    Vitreo-Retinal Research Lab, Univ of California, Davis Sch of Med, Davis, CA
  • Allan A Hunter
    Vitreo-Retinal Research Lab, Univ of California, Davis Sch of Med, Davis, CA
  • Lawrence S Morse
    Vitreo-Retinal Research Lab, Univ of California, Davis Sch of Med, Davis, CA
  • Footnotes
    Commercial Relationships Zeljka Smit-McBride, None; Kingsley Okafor, None; Anthony Nguyen, None; Matthew Bordbari, None; Amar Patel, None; Allan Hunter, None; Lawrence Morse, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5170. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Zeljka Smit-McBride, Kingsley Okafor, Anthony T Nguyen, Matthew Bordbari, Amar P Patel, Allan A Hunter, Lawrence S Morse; Comparative expression analysisin plasma ofcirculating microRNAs identified in ocular fluids as putative biomarkers for diabetic retinopathy . Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5170.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Our goal was to establish whether miRNA biomarkers, which we identified in the ocular fluids as putative biomarkers for diabetic retinopathy, are also differentially expressed in plasma.

Methods: Plasma, aqueous and vitreous samples were collected from 10 controls and 20 patients with diabetes undergoing vitreoretinal surgery [diabetes Type I (DR-I), Type II (DR-II) and Type II, no retinopathy (NoDR-II)]. Samples were stored at -80oC. MicroRNAs from plasma were isolated using Exiqon RNA purification kit, quantified on BioAnalyzer, labeled with FlashTag kit and profiled on Affymetrix GeneChip miRNA 3.0 microarrays. Data analysis was performed using Expression Console (EC) and Transcription Analysis Console (TAC) (Affymetrix) and for pathway analysis Ingenuity Pathway Analysis software (IPA) was used. qPCR using Taqman assays is used to confirm the candidate microRNAs.

Results: Our comparison of circulatory microRNAs from aqueous and vitreous humor with corresponding plasma samples from the same patients showed that we can detect statistically significant dysregulation of some of the members from the let-7 and miR-320 families (p<0.05; -1.5>Fold Change (FC)>1.5). In DR-I group let-7 microRNAs are upregulated in the ocular fluids (FC=1.5-16) and downregulated in plasma (FC=-1.41 to -4.38), while miR-320 microRNAs are upregulated both in vitreous (FC=5.1) and plasma (FC=1.24). In DR-II group let-7 microRNAs are upregulated in ocular fluids (FC=2.12-6.1), and not detectable in the significant cut off in the plasma. In NoDR II group we observed upregulation of let-7 family members both in aqueous (FC=3.69) and in plasma (FC=3.81). Pathway analysis of the let-7 family of miRNAs shows that some of the biological pathways that they regulate are TGF-beta, Insulin Receptor Signaling, Apoptosis and VEGF Receptor Signaling. MiR-320 family has been assigned biological process by GO as cellular response to glucose stimulus and has a role in apoptosis, migration, proliferation, and signaling in diabetes mellitus.

Conclusions: The plasma profiling of circulatory microRNAs shows that DR biomarkers identified in aqueous and vitreous fluids are also differentially regulated in plasma. A number of circulatory microRNAs have shown differential presence in normal vs. diabetic retinopathy, offering promise for further study on use of plasma for diagnostic purposes.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×